Melanoma Most Commonly Affects Adults with a Median Age of 59-65 Years
The median age at melanoma diagnosis is 59-63 years, though incidence rises exponentially with age and peaks at 65 years, with elderly patients (≥70 years) representing approximately 30-39% of all cases. 1
Age Distribution Patterns
Peak Incidence Age
- Median age at diagnosis is 59 years according to NCCN guidelines, with the median age at death being 69 years 1
- The ESMO guidelines report that melanoma incidence peaks at 65 years, though any age can be affected 1
- Approximately 30-39% of melanoma patients are ≥70 years old at diagnosis 2, 3
Age-Related Risk Progression
- Melanoma risk increases exponentially with age, yet approximately 50% of melanomas occur in individuals younger than 50 years 4
- Melanoma is one of the most common cancers in persons under 30 years of age 4
- Older adults, particularly men over 65, account for about 22% of newly diagnosed melanomas annually and represent the highest-risk demographic 1, 4
Critical Age-Related Differences in Disease Presentation
Elderly Patients (≥70 Years)
- Higher prevalence of multiple melanomas (>50% in patients >60 years) 5
- More frequent head and neck melanomas (29-34% vs. 9-20% in younger patients, p<0.001) 2, 3
- Thicker tumors at presentation: mean Breslow thickness 2.4mm vs. 1.8mm in younger patients (p<0.001) 3
- Higher proportion of T3/T4 melanomas (37% vs. 20% in younger patients) 2
- More aggressive histologic subtypes: nodular, lentigo maligna, and acral lentiginous melanomas are overrepresented 2
Younger Patients (<40 Years)
- Familial melanoma is more common (54.3% in those <40 years) 5
- Highest nevus counts and density (mean: 139.6 nevi) 5
- Better prognosis: 5-year relative survival 90-96% vs. 67-89% in elderly 6
Mortality Impact by Age
Melanoma ranks second only to adult leukemia in terms of years of potential life lost per death, reflecting its impact across age groups 1
Age-Specific Mortality Patterns
- 5-year disease-specific mortality is significantly worse in elderly patients: 16% vs. 8% in younger patients (p=0.004) 3
- Overall 5-year mortality in elderly: 30% vs. 12% in younger patients (p<0.001) 3
- Melanoma incidence and mortality continue to rise unabated in older individuals, particularly men over 65, while rates have stabilized in younger Americans 7
Clinical Pitfalls in Age-Related Diagnosis
Delayed Diagnosis in Elderly
- Diagnosis occurs more frequently in general practice settings rather than dermatology for elderly patients 2
- Time to definitive excision is longer in older patients 2
- 16.8% of elderly patients have insufficient excision margins vs. 5.0% in younger patients (p<0.001) 2
- Sentinel lymph node biopsy is underutilized: performed in only 23.3% of elderly with thick melanomas vs. 41.4% in younger patients (p<0.001) 2
Biological Differences
- Aging diminishes capacity to repair UV-induced DNA damage, contributing to higher melanoma risk 4
- Despite thicker tumors, elderly patients have fewer sentinel lymph node metastases (18% vs. 33% in T3/T4 melanomas, p=0.02) 3
- Higher rate of local and in-transit recurrences in elderly: 14.5% vs. 3.4% at 5 years (p<0.001) 3
Incidence Trends by Age Group
Between 1989 and 2015, age-standardized melanoma incidence in older men increased from 18 to 103 per 100,000 person-years, representing a nearly 6-fold increase 6
- In older women: increased from 23 to 70 per 100,000 person-years 6
- In younger men: increased from 8 to 21 per 100,000 person-years 6
- In younger women: increased from 13 to 28 per 100,000 person-years 6
The gap in melanoma incidence between younger and older people is widening due to the disproportionate increase in elderly populations 6